MELISSA THOMPSON: Open Payments
NPI 1245677673 · ORANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 41 payments from 11 companies in 2025. Trend: 2023 $681 · 2024 $709 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $204 |
| AstraZeneca Pharmaceuticals LP | 7 | $190 |
| ABBVIE INC. | 5 | $95 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| PFIZER INC. | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Mannkind Corporation | 1 | $21 |
| Amgen Inc. | 1 | $18 |
Products named: FARXIGA, Wegovy, VRAYLAR, Rybelsus, AIRSUPRA, ELIQUIS, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
